FDA Approval Activities for this Drug…

Precose (acarbose) Tablets, Bayer NDA 20-482/S-011 10/29/02 11/18/02 Precose (acarbose) Tablets, Bayer NDA 20-482/S-010 8/16/99 5/19/00 Precose (acarbose) Tablets, Bayer Pharmaceutical Division NDA 20-482/S-007 and S-008 9/29/98 9/29/98 12/11/98 Precose Indications: S-007- provided for the new combination use of Precose for patients with type 2 diabetes treated with diet plus insulin; and S-008- provided for the new combination of Precose for patients with type 2 diabetes with diet and metformin.

For the latest approval information, please locate this drug using this index.